GENEVA: The World Health Organisation (WHO) on Tuesday validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by Beijing-based pharmaceutical company Sinovac.
"The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe," WHO Assistant Director General for Access to Health Products, Mariangela Simao, said in a statement. "We urge manufacturers to participate in the Covax Facility, share their knowhow and data and contribute to bringing the pandemic under control," Simao added.
WHO's Emergency Use Listing (EUL) is a prerequisite for Covax facility vaccine supply and international procurement. It also allows countries to expedite their regulatory approval to import and administer Covid-19 vaccines. (IANS)
Also Watch: